Methylene Blue: a Potential Novel Treatment in Diabetic Foot Ulcer


  • Lintang Cahyaning Ratri Fakultas Kedokteran, Universitas Airlangga
  • Annisa Salsabilla Dwi Nugrahani Fakultas Kedokteran, Universitas Airlangga
  • Gwenny Ichsan Prabowo Departemen Ilmu Faal dan Biokimia Kedokteran, Universitas Airlangga, Surabaya, Indonesia
  • Jongky Hendro Prajitno Departemen Ilmu Penyakit Dalam, RSUD Dr. Soetomo, Surabaya, Indonesia



Diabetes is a chronic metabolic disease that can lead to serious consequences that impair one's quality of life, if not adequately controlled. One of the undesirable complications is diabetic foot ulcer. It is estimated globally that every 30 seconds a leg is amputated due to diabetic foot, and thus can lower the quality of life. Recent studies have used a low-cost dye known as methylene blue as an anti-microorganism agent, and this sparks the idea of exploring more of its possible benefits. This literature review aimed to outline the beneficial roles of methylene blue in diabetic foot ulcer treatment. According to the findings, it is said that methylene blue may play a role as an anti-microorganism agent through its contribution in wound healing and invasive surgical prevention such as limb amputation. All the pooled articles showed a promising outcome of MB from the reduction of wound size in a shorter healing period with none adverse effects reported. Hence, methylene blue may have a promising role to be an effective agent in treating diabetic foot ulcer.


American Diabetes Association. Introduction: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022;45:S1–2.

International Diabetes Federation. IDF Diabetes Atlas 9th Edition. International Diabetes Federation 2019. (accessed June 29, 2022).

CDC. National Diabetes Statistics Report 2020. Estimates of diabetes and its burden in the United States. 2020.

World Health Organization. CLASSIFICATION OF DIABETES MELLITUS 2019 Classification of diabetes mellitus. 2019.

Armstrong DG, Fisher TK, Lepow B, White ML, Mills JL. Pathophysiology and Principles of Management of the Diabetic Foot. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists 2011:475–96.

Barnes JA, Eid MA, Creager MA, Goodney PP. Arteriosclerosis, Thrombosis, and Vascular Biology ATVB IN FOCUS: Peripheral Artery Disease Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease. Arterioscler Thromb Vasc Biol 2020;40:1808–17.

Azmi S, ElHadd KT, Nelson A, Chapman A, Bowling FL, Perumbalath A, et al. Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review. Diabetes Therapy 2019;10:35.

Bandyk DF. The diabetic foot: Pathophysiology, evaluation, and treatment. Semin Vasc Surg 2018;31:43–8.

Lim JZM, Ng NSL, Thomas C. Prevention and treatment of diabetic foot ulcers: Http://DxDoiOrg/101177/0141076816688346 2017;110:104–9.

American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021;44:S15–33.

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci 2020;21:1–34.

Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature 2019;576:51–60.

Spanakis EK, Golden SH. Race/Ethnic Difference in Diabetes and Diabetic Complications. Curr Diab Rep 2013;13:814–23.

Ai-hong W, Zhang-rong X, Li-nong J. Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China. National Medical Journal of China 2012;92:224–7.

Sumpio BE. Contemporary Evaluation and Management of the Diabetic Foot. Scientifica (Cairo) 2012;2012:1–17.

Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:136–54.

American Diabetes Association. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020. Diabetes Care 2020;43:S135–51.

Aumiller WD, Dollahite HA. Pathogenesis and management of diabetic foot ulcers. J Am Acad Physician Assist 2015;28:28–34.

Pannier F, Rabe E. Differential diagnosis of leg ulcers: Http://DxDoiOrg/101177/0268355513477066 2013;28:55–60.

You H, Han S, Rhie J. Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers. J Wound Care 2014;23:521–30.

Hanley ME, Manna B. Hyperbaric Treatment Of Diabetic Foot Ulcer. StatPearls 2021.

MATOS DR, NAVES JF, ARAUJO TCCF de. Quality of life of patients with lower limb amputation with prostheses. Estudos de Psicologia (Campinas) 2019;37.

Coutts PM, Ryan J, Sibbald RG. Case series of lower-extremity chronic wounds managed with an antibacterial foam dressing bound with gentian violet and methylene blue. Adv Skin Wound Care 2014;27:9–13.

Woo KY, Heil J. A prospective evaluation of methylene blue and gentian violet dressing for management of chronic wounds with local infection. Int Wound J 2017;14:1029.

Lullove EJ. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study. vol. 29. 2017.

Tardivo JP, Adami F, Correa JA, Pinhal MA parecida S, Baptista MS. A clinical trial testing the efficacy of PDT in preventing amputation in diabetic patients. Photodiagnosis Photodyn Ther 2014;11:342–50.

Tardivo JP, Serrano R, Zimmermann LM, Matos LL, Baptista MS, Pinhal MAS, et al. Is surgical debridement necessary in the diabetic foot treated with photodynamic therapy? Diabet Foot Ankle 2017;8.

Carrinho PM, Andreani DIK, Morete VDA, Iseri S, Navarro RS, Villaverde AB. A Study on the Macroscopic Morphometry of the Lesion Area on Diabetic Ulcers in Humans Treated with Photodynamic Therapy Using Two Methods of Measurement. Photomed Laser Surg 2018;36:44–50.

Kashef N, Djavid GE, Siroosy M, Khani AT, Zokai FH, Fateh M. Photodynamic inactivation of drug-resistant bacteria isolated from diabetic foot ulcers. Iran J Microbiol 2011;3:36.

Scigliano G, Scigliano GA. Methylene blue in covid-19. Med Hypotheses 2021;146.

Pardo Andreu GL. The rationale for methylene blue utility against SARS-CoV-2 infection complications [Fundamentación de la utilidad del azul de metileno contra las complicaciones de la infección por SARS-CoV-2]. © 2021 Journal of Pharmacy & Pharmacognosy Research 2021;9:379–96.

Denny JT, Burr AT, Balzer F, Tse JT, Denny JE, Chyu D. Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review. Exp Ther Med 2015;9:1915–20.

Tariq R, Khalid UA, Kanwal S, Adnan F, Qasim M. Photodynamic Therapy: A Rational Approach Toward COVID-19 Management. J Explor Res Pharmacol 2021;000:000–000.

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. PHOTODYNAMIC THERAPY OF CANCER: AN UPDATE. CA Cancer J Clin 2011;61:250.

Amigo BR. Light-sensitive nanocarriers for drug delivery in photodynamic therapy. n.d.

Broekgaarden M, Weijer R, van Gulik TM, Hamblin MR, Heger M. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev 2015;34:643.

Maisch T. Resistance in antimicrobial photodynamic inactivation of bacteria. Photochemical & Photobiological Sciences 2015 14:8 2015;14:1518–26.

Shen X, Dong L, He X, Zhao C, Zhang W, Li X, et al. Treatment of infected wounds with methylene blue photodynamic therapy: An effective and safe treatment method. Photodiagnosis Photodyn Ther 2020;32:102051.

Ghorbani J, Rahban D, Aghamiri S, Teymouri A, Bahador A. Photosensitizers in antibacterial photodynamic therapy: an overview. Laser Ther 2018;27:293.

Bardellini E, Veneri F, Amadori F, Conti G, Majorana A. Photobiomodulation therapy for the management of recurrent aphthous sto-matitis in children: Clinical effectiveness and parental satisfaction. Med Oral Patol Oral Cir Bucal 2020;25:e549–53.

Oyama J, Fernandes Herculano Ramos-Milaré ÁC, Lopes Lera-Nonose DSS, Nesi-Reis V, Galhardo Demarchi I, Alessi Aristides SM, et al. Photodynamic therapy in wound healing in vivo: a systematic review. Photodiagnosis Photodyn Ther 2020;30.

Gary Sibbald R, Ovington LG, Ayello EA, Goodman L, Elliott JA. Wound bed preparation 2014 update: Management of critical colonization with a gentian violet and methylene blue absorbent antibacterial dressing and elevated levels of matrix metalloproteases with an ovine collagen extracellular matrix dressing. Adv Skin Wound Care 2014;27:1–6.

Sharma R, Gupta N, Kumar V, Pal S, Kaundal V, Sharma V. Silver colloid dressings score over conventional dressings in diabetic foot ulcer: a randomized clinical trial. International Surgery Journal 2017;4:2627–31.

McDonagh EM, Bautista JM, Youngster I, Altman RB, Klein TE. PharmGKB summary: Methylene blue pathway. Pharmacogenet Genomics 2013;23:498–508.

Sikka P, Bindra VK, Kapoor S, Jain V, Saxena KK. Blue cures blue but be cautious. J Pharm Bioallied Sci 2011;3:543.

Lee JH, Chang CH, Park CH, Kim J-K. Methylene Blue Dye-Induced Skin Necrosis in Immediate Breast Reconstruction: Evaluation and Management. Arch Plast Surg 2014;41:258.




How to Cite

Ratri, L. C., Nugrahani, A. S. D., Prabowo, G. I., & Prajitno, J. H. (2022). Methylene Blue: a Potential Novel Treatment in Diabetic Foot Ulcer. Jurnal Profesi Medika : Jurnal Kedokteran Dan Kesehatan, 16(2).